Physician profile
Leroy A Smith
NPI 1457453532
$4,507.24
in general payments reported to CMS, 2019-2025
24 companies · $696 in 2025
The $696 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $808 · 2020: $344 · 2022: $932 · 2023: $829 · 2024: $899 · 2025: $696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,262 · Education: $137 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,262.03 |
| Education | $137.01 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $619.80 | 2019-2024 | |
| Aroa Biosurgery Incorporated | $434.80 | 2022-2023 | |
| Csl Behring | $341.97 | 2020-2025 | Kcentra |
| Stryker Corporation | $307.43 | 2022-2025 | Cascadia Interbody System |
| Pacira Pharmaceuticals Incorporated | $246.82 | 2020-2023 | Iovera |
| Kci USA, INC. | $211.63 | 2019-2022 | |
| Atricure, INC. | $165.83 | 2024 | |
| Davol INC. | $164.64 | 2023-2024 | Phasix Mesh |
| Innovation Technologies INC | $163.80 | 2025 | Irrisept |
| Acumed LLC | $157.93 | 2023 | Ribloc |
| Tela Bio, INC. | $150.81 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $149.11 | 2023 | Caldolor |
| Kerecis Limited | $147.76 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Eagle Pharmaceuticals, INC. | $127.51 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $125.00 | 2019 | |
| Merck Sharp & Dohme LLC | $125.00 | 2019 | |
| Baxter Healthcare | $125.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $118.24 | 2025 | Gattex |
| Covidien LP | $103.13 | 2019 | |
| W. L. Gore & Associates, INC. | $100.72 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Medline Industries LP | $99.82 | 2019 | |
| Abbott Laboratories | $98.69 | 2020 | |
| Heron Therapeutics, INC. | $96.80 | 2023 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leroy Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.